A MACHINE LEARNING MODEL FOR THE PROGNOSIS OF ALZHEIMER’S DISEASE DEMENTIA AT THE MILD COGNITIVE IMPAIRMENT STAGE USING MITOCHONDRIAL METHYLCYTOSINES AS NOVEL BLOOD‐BASED BIOMARKERS | Publicación